Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Rx Import Laws Would Not Be Blocked By Australia Trade Deal, USTR Says

Executive Summary

The U.S.-Australia free trade agreement moving through Congress underscores the right of manufacturers to control resale of their products across national borders

You may also be interested in...



Importation Limits In Future Trade Agreements Prevented Under Vitter Bill

Pharmaceutical importation prohibitions in future U.S. trade agreements would be forbidden under a bill co-sponsored by Sens. David Vitter (R-La.) and Debbie Stabenow (D-Mich.)

Importation Limits In Future Trade Agreements Prevented Under Vitter Bill

Pharmaceutical importation prohibitions in future U.S. trade agreements would be forbidden under a bill co-sponsored by Sens. David Vitter (R-La.) and Debbie Stabenow (D-Mich.)

Rx Imports Would Be Protected In U.S. Trade Deals Under House Measure

U.S. trade negotiators would be prohibited from blocking prescription drug importation in future trade agreements under an amendment added to a fiscal year 2006 appropriations bill

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS044333

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel